LLY · News · 20261030N
Medicare GLP-1 Bridge Program
ELI LILLY & Co · 2026-10-30 · Importance 34 · Surprise 42 · In source text
Eli Lilly said it expanded U.S. access to obesity medicines through the Medicare GLP-1 Bridge Program. Management cited approximately 20 million seniors as the population for whom access was expanded. The report gives no further detail on program duration, coverage terms, or financial impact.
Key facts
- Eli Lilly expanded U.S. access to obesity medicines to approximately 20 million seniors through the Medicare GLP-1 Bridge Program. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | contingent | — | Eli Lilly expanded U.S. access to obesity medicines to approximately 20 million seniors through the Medicare GLP-1 Bridge Program. |